Dysregulation of TH type cytokines in the patients of Parthenium induced contact dermatitis

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 2024-2028

  Akhtar, Nasim ^a   Satyam, Abhigyan ^a   Anand, Vivek ^a   Verma, K K ^a   Khatri, Rakesh ^b   Sharma, Alpana ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Air borne contact dermatitis; Allergens; Hypersensitivity; Parthenium dermatitis; Parthenium hysterophorus; TH1 TH2 TH17 Treg Cytokines

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTACT DERMATITIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOGLOBULIN AGGREGATE; IMMUNOPATHOGENESIS; MALE; PARTHENIUM HYSTEROPHORUS; PATCH TEST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; SENSITIVITY AND SPECIFICITY; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; WEED;

ADULT; AGED; CASE-CONTROL STUDIES; CYTOKINES; DERMATITIS, CONTACT; FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

PARTHENIUM; PARTHENIUM HYSTEROPHORUS;

EID: 77957748909     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.030     Document Type: Article

References (43)

1. Barnes P.J. Biochemistry of asthma. Trends Biochem Sci 1991, 6(10):365-369.
2. Wuthrich B. Epidemiology of the allergic diseases: are they really on the increase?. Int Arch Allergy Appl Immunol 1989, 90(Suppl 1):3-10.
3. Lonkar A., Nagasampage B.A., Narayanan C.R., Landge A.B., Sawaikar D.D. An antigen from Parthenium hysterophorus Linn. Contact Dermat 1976, 2:151-154.
4. Verma K.K., Mahesh R., Srivastava P., Ramam M., Mukhopadhyaya A.K. Azathioprine versus betamethasone for the treatment of parthenium dermatitis: a randomized controlled study. Indian J Dermatol Venereol Leprol 2008, 74(5):453-457.
5. Towers G.H.N., Mitchell J.C. Current status of weed Parthenium hysterophorus L. as a cause of allergic contact dermatitis. Contact Dermat 1983, 9:465-469.
6. Verma K.K., Manchanda Y., Dwivedi S.N. Failure of titer of contact hypersensitivity to correlate with clinical severity and therapeutic response in contact dermatitis caused by parthenium. Indian J Dermatol Venereol Leprol 2004, 70(4):210-213.
7. Mitchell J.C. Parthenium pollen - Parthenium dermatitis. Contact Dermat 1981, 7(4):212-213.
8. Rodríguez E., Dillon M.O., Mabry T.J., Mitchell J.C., Towers G.H.N. Dermatologically active sesquiterpene lactones in trichomes of Parthenium hysterophorus Linn. (Compositae). Cell Mol Life Sci 1976, 32(2):236-238.
9. Verma K.K., Sirka C.S., Ramam M., Sharma V.K. Parthenium dermatitis presenting as photosensitive lichenoid eruption. A new clinical variant. Contact Dermat 2002, 46:286-289.
10. Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998, 19:37-44.
11. H2 paradigm. Scand J Immunol 1998, 47:1-9.
12. Kurts C. Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity. Nephrol Dial Transplant 2008, 23(3):816-819.
13. Chung F. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-g. Mediat Inflamm 2001, 10:51-59.
14. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6(11):1123-1132.
15. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
16. + T cells. Immunol Rev 1991, 123:209-229.
17. H2 subsets: doubt no more. Immunol Today 1991, 12:256-257.
18. Fullmer M.A., Shen J.Y., Modlin R.L., Rea T.H. Immunohistological evidence of lymphokine production and lymphocyte activation antigen in tuberculin reactions. Clin Exp Immunol 1987, 67:383-390.
19. Toebak M.J., Moed H., Blomberg B.M.E.V., Bruynzeel D.P., Gibbs S., Scheper R.J., et al. Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells. Contact Dermat 2006, 55(4):238-245.
20. Magnan A., Mély L., Prato S., Vervloet D., Romagné F., Camilla C., et al. Relationships between natural T cells, atopy, IgE levels, and IL-4 production. Allergy 2000, 55(3):286-290.
21. Geha R.S. Human IgE. J Allergy Clin Immunol 1984, 74(2):109-120.
22. Sutton B.J., Gould H.J. The human IgE network. Nature 1993, 366:421-428.
23. Verma K.K., Manchanda Y., Dwivedi S.N. Failure of titer of contact hypersensitivity to correlate with clinical severity and therapeutic response in contact dermatitis caused by parthenium. Indian J Dermatol Venereol Leprol 2004, 70(4):210-213.
24. Bajaj A.K., Saraswat A., Mukhija G., Rastogi S., Yadav S. Patch testing experience with 1000 patients. Indian J Dermatol Venereol Leprol 2007, 73(5):313-318.
25. Kapsenberg M.L., Wieranga E.A., Stiekema F.E., Tiggelman A.M., Bos J.D. Th1 lymphokine production profiles of nickel-specific CD4+ T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 1992, 98:59-63.
26. H2 cytokines in the pathogenesis of autoimmune skin disease - pemphigus vulgaris. Immunol Invest 2009, 38(6):498-509.
27. Sharma A., Rajappa M., Saxena A., Sharma M. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer 2007, 17(4):879-885.
28. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998, 8:275-283.
29. H17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol 2009, 123:486-492.
30. H17 and regulatory T cells. Nature 2006, 441:235-238.
31. H17 lineage. Nature 2006, 441:231-234.
32. Caproni M., Antiga E., Melani L., Volpi W., Del Bianco E., Fabbri P. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol 2009, 29:210-214.
33. Akhtar N, Verma KK, Sharma A. Study of pro- and anti-inflammatory cytokine profile in the patients with parthenium dermatitis. Contact Dermatitis. 2010 Jul 29. [Epub ahead of print].
34. Homey B., Steinhoff M., Ruzicka T., Leung D.Y.M. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006, 118:78-89.
35. Hawrylowicz C.M., O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005, 5:271-283.
36. Yagi J., Arimura Y., Takatori H., Nakajima H., Iwamoto I., Uchiyama T. Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+ T cells. Int Immuno 2006, 18(12):1681-1690.
37. Stingeni Agea, Lisi Spinozzi T-lymphocyte cytokine profiles in compositae airborne dermatitis. Br J Dermatol 1999, 141(4):689-693.
38. H2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999, 103(8):1103-1111.
39. Wong C.K., Ho C.Y., Ko F.W.S., Chan C.H.S., Ho A.S.S., Hui D.S.C., et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-g, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001, 125:177-183.
40. Sharma A., Satyam A., Sharma J.B. Leptin, IL-10 and inflammatory markers (TNF-α, IL-6 & IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007, 58(1):21-30.
41. Vercelli D., Geha R. Regulation of isotype switching. Curr Opin Immunol 1992, 4:794-797.
42. Ohameje N.U., Loveless J.W., Saini S.S. Atopic dermatitis or hyper-IgE syndrome?. Allergy Asthma Proc 2006, 27:289-291.
43. Durham S.R., Ying S., Varney V.A., Jacobson M.R., Sudderick R.M., Mackay I.S. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992, 148:2390-2394.